Vicore Pharma Holding AB (OSTO:VICO BTA) Other Operating Expense : kr0.40 Mil (TTM As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Vicore Pharma Holding AB Other Operating Expense?

Vicore Pharma Holding AB's Other Operating Expense for the three months ended in Mar. 2025 was kr-0.42 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.40 Mil.

Vicore Pharma Holding AB's quarterly Other Operating Expense increased from Sep. 2024 (kr-0.22 Mil) to Dec. 2024 (kr0.63 Mil) but then declined from Dec. 2024 (kr0.63 Mil) to Mar. 2025 (kr-0.42 Mil).

Vicore Pharma Holding AB's annual Other Operating Expense increased from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil) but then declined from Dec. 2023 (kr0.00 Mil) to Dec. 2024 (kr0.00 Mil).

Vicore Pharma Holding AB Other Operating Expense Historical Data

The historical data trend for Vicore Pharma Holding AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Other Operating Expense Chart

Vicore Pharma Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

-17.54

Vicore Pharma Holding AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															3.01	0.40	-0.22	0.63	-0.42

Vicore Pharma Holding AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.40 Mil.

Vicore Pharma Holding AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicore Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO BTA) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

VICO:Sweden

Address

Kornhamnstorg 53, Stockholm, SWE, 111 27

Website

https://www.vicorepharma.com

Vicore Pharma Holding AB is a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2b development for IPF. The company also has an investigational medical device in clinical development, namely, Almee, which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines